Bacteremia Due to Fluoroquinolone-Resistant Campylobacter jejuni in an Immunocompetent Child

Tajada, Pilar; Alós, Juan-Ignacio; Gómez-Garcés, José Luís; Aybar, Luis

doi:10.1016/s0196-4399(97)87666-0

Cited by 4 publications

(2 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Amoxicillin susceptibility contrast previous report Tajada et al, (1996) that organisms are resistant to a large number of betalactams particularly ampicillin and amoxicillin. The isolates were moderately susceptible to erythromycin, ciprofloxacin, and levofloxacin.…”

Section: Resultscontrasting

confidence: 72%

Isolation and Antibiotic Susceptibility of Campylobacter Species from Cattle Offals in Gwagwalada Abattoir, Abuja-FCT Nigeria

Olabode¹,

Ogbole²,

Ifeanyi³

et al. 2017

Int.J.Curr.Microbiol.App.Sci

View full text Add to dashboard Cite

Section: Resultscontrasting

confidence: 72%

Isolation and Antibiotic Susceptibility of Campylobacter Species from Cattle Offals in Gwagwalada Abattoir, Abuja-FCT Nigeria

Olabode¹,

Ogbole²,

Ifeanyi³

et al. 2017

Int.J.Curr.Microbiol.App.Sci

View full text Add to dashboard Cite

“…One study reported comparisons between FQR and susceptible cases with regard to muscle aches, painful joints, weakness and headache, but found no significant difference between these groups for any of these outcomes [30] (Table S7). The remaining BOI measures, reduced appetite, night sweats, severe polar, progressive pain in upper extremities due to osteomyelitis, ileocolitis, pharyngotonsillitis and urinary tract infection, were observed in five case reports [42][43][44][45][46] (Table S7).…”

Section: Nauseamentioning

confidence: 99%

Characterisation of burden of illness measures associated with human (Fluoro)quinolone-resistant Campylobacter spp. infections – a scoping review

et al. 2022

View full text Add to dashboard Cite

Campylobacter spp. are one of the most common causes of bacterial gastroenteritis in Canada and worldwide. Fluoroquinolones are often used to treat complicated human campylobacteriosis and strains of Campylobacter spp. resistant to these drugs are emerging along the food chain. A scoping review was conducted to summarize how human (fluoro)quinolone-resistant (FQR; quinolones including fluoroquinolones) Campylobacter spp. infections are characterized in the literature by describing how burden of illness (BOI) associated with FQR is measured and reported, describing the variability in reporting of study characteristics, and providing a narrative review of literature that compare BOI measures of FQR Campylobacter spp. infections to those with susceptible infections. The review identified 26 studies that yielded many case reports, a lack of recent literature, and a lack of Canadian data.Studies reported 26 different BOI measures and the most common were hospitalization, diarrhea, fever, and duration of illness. There were mixed results as BOI measures reported in literature were inconsistently defined and there were limited comparisons between resistant and susceptible infections. This presents a challenge when attempting to assess the magnitude of the BOI due to FQR Campylobacter spp., highlighting the need for more research in this area.

show abstract

Activity of BMS284756 (T-3811) tested against anaerobic bacteria, Campylobacter jejuni, Helicobacter pylori and Legionella spp.

Rhomberg

Biedenbach

Jones

2001

Diagnostic Microbiology and Infectious Disease

View full text Add to dashboard Cite

Bacteremia Due to Fluoroquinolone-Resistant Campylobacter jejuni in an Immunocompetent Child

Cited by 4 publications

References 10 publications

Isolation and Antibiotic Susceptibility of Campylobacter Species from Cattle Offals in Gwagwalada Abattoir, Abuja-FCT Nigeria

Isolation and Antibiotic Susceptibility of Campylobacter Species from Cattle Offals in Gwagwalada Abattoir, Abuja-FCT Nigeria

Characterisation of burden of illness measures associated with human (Fluoro)quinolone-resistant Campylobacter spp. infections – a scoping review

Activity of BMS284756 (T-3811) tested against anaerobic bacteria, Campylobacter jejuni, Helicobacter pylori and Legionella spp.

Contact Info

Product

Resources

About